cbdMD (YCBD) Non-Current Deferred Tax Liability (2016 - 2021)
cbdMD's (YCBD) quarterly Non-Current Deferred Tax Liability came in at $6.1 million in Q3 2021, up 583.35% year-on-year from $895000.0 in Q3 2020, and up 4604.62% quarter-over-quarter from $130000.0 in Q2 2021.
cbdMD (YCBD) Non-Current Deferred Tax Liability (2016 - 2021) Analysis & Trends
cbdMD has disclosed Non-Current Deferred Tax Liability across 6 years of filings, most recently posting $6.1 million for Q3 2021.
- Non-Current Deferred Tax Liability for Q3 2021 came in at $6.1 million, up 583.35% year-over-year; the trailing twelve-month figure through Sep 2021 was $6.1 million (up 583.35% YoY), and the FY2021 annual result was $6.1 million, up 583.35% from the prior year.
- Non-Current Deferred Tax Liability came in at $6.1 million for Q3 2021 at cbdMD, up from $130000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $6.1 million in Q3 2021 to a low of $15000.0 in Q4 2017.
- The 5-year median for Non-Current Deferred Tax Liability is $563000.0 (2020), against an average of $2.0 million.
- Across the five-year window, Non-Current Deferred Tax Liability surged 33206.67% in 2018 and slumped 83.33% in 2020, its largest moves.
- cbdMD's Non-Current Deferred Tax Liability stood at $15000.0 in 2017, then soared by 33206.67% to $5.0 million in 2018, then increased by 7.47% to $5.4 million in 2019, then sank by 89.51% to $563000.0 in 2020, then jumped by 986.32% to $6.1 million in 2021.
- The last three Non-Current Deferred Tax Liability figures came in at $6.1 million (Q3 2021), $130000.0 (Q2 2021), and $27000.0 (Q1 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | cbdMD | 3,884.57 | -3.38 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 6.12 Mn |
| Sep 30, 2021 | 6.12 Mn |
| Jun 30, 2021 | 130,000.00 |
| Jun 30, 2021 | 130,000.00 |
| Mar 31, 2021 | 27,000.00 |
| Mar 31, 2021 | 27,000.00 |
| Dec 31, 2020 | 563,000.00 |
| Dec 31, 2020 | 563,000.00 |
| Sep 30, 2020 | 895,000.00 |
| Sep 30, 2020 | 895,000.00 |
| Sep 30, 2019 | 5.37 Mn |
| Sep 30, 2019 | 5.37 Mn |
| Jun 30, 2019 | 2.83 Mn |
| Jun 30, 2019 | 2.83 Mn |
| Mar 31, 2019 | 3.92 Mn |
| Mar 31, 2019 | 3.92 Mn |
| Dec 31, 2018 | 5.00 Mn |
| Dec 31, 2018 | 5.00 Mn |
| Sep 30, 2018 | 368,000.00 |
| Sep 30, 2018 | 368,000.00 |